ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,323.00
-0.04%
S&P ASX All Technology
3,880.20
0.04%
Brent Oil
72.775
-0.09%
US Dollar vs AUD
1.53506
-0.04%
Bitcoin
97,091.36
2.90%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kura Oncology Inc (KURA) Share Price

Kura Oncology Inc

Kura Oncology Inc (KURA)

NASDAQ
15.91
-0.05
(-0.31%)
Closed 21 November 8:00AM
Delayed by 15 minutes
14.25
-1.66
(-10.43%)
After Hours: 11:59AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
14.25
Bid
13.72
Offer
14.25
Volume
925,654
15.42 Day's Range 16.09
9.06 52 Week Range 24.17
Market Cap
1.108B
Previous Close
15.96
Open
15.96
Last Trade
702
@
14.25
(formt)
Last Trade Time
Financial Volume
US$ 14,632,028
VWAP
15.8072
Average Volume (3m)
593,162
Shares Outstanding
77,763,750
Dividend Yield
-
PE Ratio
-8.11
Earnings Per Share (EPS)
-1.96
Revenue
-
Net Profit
-152.63M

About Kura Oncology Inc

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more

Sector
Pharmaceutical Preparations
Industry
Blank Checks
Website
www.kuraoncology.com
Headquarters
Wilmington, Delaware, USA
Founded
2015
Kura Oncology Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KURA. The last closing price for Kura Oncology was US$15.96. Over the last year, Kura Oncology shares have traded in a share price range of US$ 9.06 to US$ 24.17.

Kura Oncology currently has 77,763,750 shares in issue. The market capitalisation of Kura Oncology is US$1.24 billion. Kura Oncology has a price to earnings ratio (PE ratio) of -8.11.

Ask ADVFN Intelligence (AI)

KURA Latest News

More News

Form 8-K - Current report

8 hours ago
Edgar (US Regulatory)

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias PR Newswire SAN DIEGO and TOKYO, Nov. 20, 2024 – Kura to receive a...

8 hours ago
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

20 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

19 November 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

08 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

08 November 2024
Edgar (US Regulatory)

Kura Oncology Reports Third Quarter 2024 Financial Results

– Topline results from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025; Phase 1 results published in The Lancet Oncology – – Data from 100 patients in Phase...

08 November 2024
GlobeNewswire Inc.

Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting

– Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r adverse risk AML patients selected for oral presentation on Saturday, December 7th – – Ziftomenib combined with ven/aza in R/R NPM1-m or...

06 November 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-4.38-23.510466988718.6319.251385276216.47194516CS
4-2.97-17.247386759617.2219.72831384129817.36375328CS
12-5.93-29.385530227920.1821.5691359316218.37367286CS
26-7.86-35.549525101822.1123.481364552019.65393883CS
524.6848.90282131669.5724.179.0690999318.67303657CS
156-2.86-16.71537112817.1124.177.4184537415.10166508CS
260-0.62-4.1694687289814.87436.3475163917.95344969CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FBRXForte Biosciences Inc
US$ 13.60
(129.53%)
28.92M
QSIQuantum Si Inc
US$ 1.39
(119.59%)
279.33M
XCURExicure Inc
US$ 11.01
(89.18%)
22.91M
AGFYAgrify Corporation
US$ 37.4635
(68.00%)
921.45k
SLXNSilexion Therapeutics Corporation
US$ 0.3495
(54.51%)
198.66M
SKKSKK Holdings Limited
US$ 4.55
(-47.28%)
816.93k
QMMMQMMM Holdings Limited
US$ 0.713999
(-43.78%)
4.61M
XTKGX3 Holdings Company Ltd
US$ 0.0901
(-37.82%)
5.95M
PRFXPainReform Ltd
US$ 1.02
(-27.14%)
5.09M
GLEGlobal Engine Group Holding Ltd
US$ 3.81
(-26.59%)
230.23k
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.191
(17.39%)
662.68M
DBGIDigital Brands Group Inc
US$ 0.1345
(15.35%)
326.45M
NVDANVIDIA Corporation
US$ 145.89
(-0.76%)
309.57M
QSIQuantum Si Inc
US$ 1.39
(119.59%)
283.09M
SLXNSilexion Therapeutics Corporation
US$ 0.3495
(54.51%)
200.06M

KURA Discussion

View Posts
Monksdream Monksdream 2 months ago
KURA rangebound
👍️0
Invest-in-America Invest-in-America 10 months ago
KURA: Yep! I noticed that too, Boss. But THANKS for your alerts about this!! (Maybe if they PR within the next hour that they are WITHDRAWING their planned shares-dump, the price will SOAR anyway!!!)
👍️0
TheFinalCD TheFinalCD 10 months ago
25.94 to $19.00 and the previous close was 18.60

so +.40 on that news


SMH

welcome to investing 2024
👍️0
Invest-in-America Invest-in-America 10 months ago
KURA: Are you frickin' KIDDING ME with this news, KURA Firm???????!!!!!!!!!
👍️0
TheFinalCD TheFinalCD 10 months ago
KURA NEWS https://www.globenewswire.com/news-release/2024/01/30/2819799/35186/en/Kura-Oncology-Reports-Positive-Preliminary-Ziftomenib-Combination-Data-in-Acute-Myeloid-Leukemia.html
👍️0
TheFinalCD TheFinalCD 10 months ago
Kura Oncology Announces Oversubscribed $150 Million Private Placement
👍️0
ClayTrader ClayTrader 5 years ago
* * $KURA Video Chart 04-28-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
seppi08162 seppi08162 5 years ago
Anybody out there? !
👍️0
stocktrademan stocktrademan 7 years ago
KURA buy 19.00



















normal chart




log chart



👍️0
Lone Wolf Lone Wolf 7 years ago
Feels risky here...feels like they're purposely notching it down a bit and ten gapping it back up above $13...wonder which side of the market incurs the greater risk if they continue to do so?!?
👍️0
Lone Wolf Lone Wolf 7 years ago
Looks like the markets are really starting to feel the bio-techs again. Yesterday and today NLNK. The day before there was some other who's ticket I forget at the moment. Today KURA. Very interesting.
👍️0
jr525 jr525 7 years ago
Just got in hope not to late
👍️0
Lone Wolf Lone Wolf 7 years ago
Looking KBIO-like squeezish!!
👍️0
Lone Wolf Lone Wolf 7 years ago
Why's that? Now it's up 60%!
👍️0
sorkin sorkin 7 years ago
May go for a ride during regular hours
👍️0
sorkin sorkin 7 years ago
Don't get sucked in buying this @30% premium here. Secondaries $6.5 will be selling on this spike
👍️0
Bearly Bullish Bearly Bullish 7 years ago
$kura long@ 8.28
👍️0
stocktrademan stocktrademan 8 years ago
KURA bullish 10.10

inverted head and shoulders bottom
http://www.google.com/search?q=inverted+head+and+shoulders+bottom









normal chart




log chart



👍️0
ClearlyStocks ClearlyStocks 8 years ago
KURA $5.89
👍️0
ClearlyStocks ClearlyStocks 8 years ago
KURA $5.75
👍️0
ClearlyStocks ClearlyStocks 8 years ago
KURA $5.66 on radar
👍️0
stock_observer_77 stock_observer_77 8 years ago
Getting close - watch for the turn up
👍️0
ClayTrader ClayTrader 8 years ago
* * $KURA Video Chart 08-11-16 * *

Link to Video - click here to watch the technical chart video
👍️0
INTL INTL 8 years ago
Come to Poppa
👍️0
Goldmind Goldmind 8 years ago
$13,000 for me:)
👍️0
Goldmind Goldmind 8 years ago
Weeeeeeeee
👍️0
logic_guy logic_guy 8 years ago
sorry 6.70
👍️0
logic_guy logic_guy 8 years ago
Thanks - sold in the pre market today - Nice chunk of change 3.80s to 4.70
👍️0
stock_observer_77 stock_observer_77 8 years ago
Congrats!!!
👍️0
logic_guy logic_guy 8 years ago
http://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+0810%3A+(KURA)+(ANW)+(CHK)+Higher%3B+(AVGR)+(OMER)+(SHAK)+Lower+(more...)/11926857.html
👍️0
logic_guy logic_guy 8 years ago
My average in the 3.80s had paid off - Nice after hours action on earnings upto 6.50 earlier high on July 15!
👍️0
ClearlyStocks ClearlyStocks 8 years ago
Wow. Run on earnings
👍️0
stocktrademan stocktrademan 8 years ago
KURA bullish 4.06




👍️0
logic_guy logic_guy 8 years ago
Kura back to green after a few days rest from 6.50
👍️0
logic_guy logic_guy 8 years ago
Took a pos at 3.90 again for a rebound back to the 5s
👍️0
logic_guy logic_guy 8 years ago
Hard to catch optt at 14.60s but she is trying lol
👍️0
logic_guy logic_guy 8 years ago
only problem is optt has 2m float this one in the tens of M range
👍️0
ClearlyStocks ClearlyStocks 8 years ago
She is lol
👍️0
TheFinalCD TheFinalCD 8 years ago
KURA pb 4.41
👍️0
logic_guy logic_guy 8 years ago
Should take inspi from optt lol
👍️0
ClearlyStocks ClearlyStocks 8 years ago
$4.95 from $4.30 call. Breaks $5 and flies
👍️0
stocktrademan stocktrademan 8 years ago
KURA bullish 4.69

bull flag



👍️0
logic_guy logic_guy 8 years ago
6.50 was the earlier high on July 15.. Should reach at least 6 this time
👍️0
ClearlyStocks ClearlyStocks 8 years ago
Nice!!!! Congrats
👍️0
logic_guy logic_guy 8 years ago
Wow KURA is following OPTT rise ---
What a coincidence ! - My price in was 4.299 lol
07/19/2016 10:20:24 Bought ???? KURA @ 4.2999
👍️0
ClearlyStocks ClearlyStocks 8 years ago
In $4.3
👍️0
ClearlyStocks ClearlyStocks 8 years ago
About to go again
👍️0
Warchest Warchest 8 years ago
trying to extend that chart cant do much more without a dip
👍️0
Warchest Warchest 8 years ago
$6.40 mac60 line pinched to sell trigger
👍️0
Warchest Warchest 8 years ago
$$ boom $6.19 mac60 peaked sell trigger 3 min away
👍️0

Your Recent History

NASDAQ
KURA
Kura Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved